Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

[up] Up a level
Number of items: 55.

Kamudoni, Paul, Poole, Christopher David and Davies, Stephen J. 2016. An estimate of the economic burden of vitamin D deficiency in pregnant women in the United Kingdom. Gynecological Endocrinology 32 (8) , pp. 592-597. 10.3109/09513590.2016.1160374

Poole, Christopher David, Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480, Andreasen, Jakob, Andersen, Jens and Currie, Craig John 2014. Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health and Quality of Life Outcomes 12 (1) , 99. 10.1186/1477-7525-12-99
file

Berni, E, Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480, Poole, Christopher David, Conway, P., Nanuwa, K. and Currie, Craig John 2014. PWE-154 the first evaluation of the relationship between the chronic liver disease questionnaire and the Eq-5d index In hepatic encephalopathy patients treated with Rifaximin-a. Gut 63 (Suppl) , A192. 10.1136/gutjnl-2014-307263.414

Poole, Christopher David, Conway, P., Nanuwa, K., Joseph, B., Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480 and Currie, Craig John 2014. PWE-153 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy. Gut 63 (Suppl) , A191. 10.1136/gutjnl-2014-307263.413

Poole, Christopher David, Conway, P., Nanuwa, K., Joseph, B., Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480 and Currie, Craig John 2014. P451 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy. Journal of Hepatology 60 (1) , S219. 10.1016/S0168-8278(14)60613-9

Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480, Poole, Christopher David, Jenkins-Jones, Sara, Morgan, Christopher L., Elwyn, Glyn ORCID: https://orcid.org/0000-0002-0917-6286, Spasic, Irena ORCID: https://orcid.org/0000-0002-8132-3885 and Currie, Craig John 2014. External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care 37 (2) , pp. 537-545. 10.2337/dc13-1159
file

Andreasen, Jakob N., Poole, Christopher David, Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480, Andersen, Jens and Serup-Hansen, Niels 2014. EQ-5D health utility values in the treatment Of seasonal grass pollen induced rhinoconjunctivitis. Journal of Allergy and Clinical Immunology 133 (2S) , AB222. 10.1016/j.jaci.2013.12.793

Bannister, Christian ORCID: https://orcid.org/0000-0001-8558-9480, Poole, Christopher David, Jenkins-Jones, Sara, Morgan, Christopher L., Currie, Craig and Elwyn, Glyn 2013. Orals: validation of UKPDS risk engine predictions among patients with type 2 diabetes routinely managed in UK primary care. Diabetes 62 (Supp 1) , A71-A71. 10.2337/db13-1-387

Currie, Craig John, Poole, Christopher David, Evans, Marc, Peters, John Redmond and Morgan, Christopher L. 2013. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. Journal of Clinical Endocrinology & Metabolism 98 (2) , pp. 668-677. 10.1210/jc.2012-3042
file

Poole, Christopher David, Halcox, Julian, Jenkins-Jones, Sara, Carr, Emma S.M., Schifflers, Mathias G., Ray, Kausik K. and Currie, Craig J. 2013. Omega-3 fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study. Clinical Therapeutics 35 (1) , pp. 40-51. 10.1016/j.clinthera.2012.11.008
file

Morgan, Christopher L., Poole, Christopher David, Evans, Marc, Barnett, Anthony H., Jenkins-Jones, Sara and Currie, Craig John 2012. What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. Journal of Clinical Endocrinology & Metabolism 97 (12) , p. 4605. 10.1210/jc.2012-3034

Currie, Craig John, Peyrot, M., Morgan, Christopher L., Poole, Christopher David, Jenkins-Jones, Sara, Rubin, Richard R., Burton, Christopher M. and Evans, Marc 2012. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 35 (6) , pp. 1279-1284. 10.2337/dc11-1277

Poole, Christopher David, Morgan, Christopher L., Conway, P. and Currie, Craig John 2012. PSU1 Adverse events commonly associated with opioid use: impact upon length of stay following surgical procedure [Abstract]. Value In Health 15 (4) , A73. 10.1016/j.jval.2012.03.404

Poole, Christopher David, Currie, Craig John, Holden, Sarah E. and Singh, A. 2012. PMS19 Impact of disease severity on the total, health-related, financial costs of treatment of people with rheumatoid arthritis in the United Kingdom [Abstract]. Value In Health 15 (4) , A36-A37. 10.1016/j.jval.2012.03.208

Morgan, Christopher L., Jenkins-Jones, Sara, Evans, Meirion Rhys ORCID: https://orcid.org/0000-0003-3578-1866, Barnett, A. H., Poole, Christopher David and Currie, Craig John 2012. Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes, Obesity and Metabolism 14 (5) , pp. 424-432. 10.1111/j.1463-1326.2011.01552.x

Currie, Craig John, Poole, Christopher David, Jenkins-Jones, Sara, Gale, E. A. M., Johnson, J. A. and Morgan, Christopher L. 2012. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 35 (2) , pp. 299-304. 10.2337/dc11-1313

Holden, Sarah E., Poole, Christopher David, Morgan, Christopher L. and Currie, Craig John 2011. Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. British Medical Journal Open 1 (2) , e000258. 10.1136/bmjopen-2011-000258
file

Morgan, Christopher L., Evans, Marc, Toft, Anders D., Jenkins-Jones, Sara, Poole, Christopher David and Currie, Craig John 2011. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study. Clinical Therapeutics 33 (1) , pp. 27-35. 10.1016/j.clinthera.2011.01.023

Dixon, Simon, Poole, Christopher David, Odeyemi, Isaac, Retsa, Peny, Chambers, Colette and Currie, Craig John 2011. Deriving health state utilities for the numerical pain rating scale. Health and Quality of Life Outcomes 9 , pp. 96-104. 10.1186/1477-7525-9-96
file

Poole, Christopher David, Singh, A., Freundlich, B., Koenig, A. and Currie, Craig John 2010. PMS2 Estimating health-based utility from clinically assessed disease severity in ankylosing spondylitis [Abstract]. Value in Health 13 (3) , A122. 10.1016/S1098-3015(10)72590-0

Currie, Craig John, Poole, Christopher David, Singh, A. and Reynolds, A. 2010. PMS17 Estimation of costs of health care for people with rheumatoid arthritis for varying degrees of disability as measured by the health assessment questionnaire in the United Kingdom [Abstract]. Value in Health 13 (3) , A125. 10.1016/S1098-3015(10)72605-X

Poole, Christopher David, Evans, Louise Marie, Peters, John Redmond and Currie, Craig John 2010. PDB10 Survival as a function of HBA1C in people with type 2 diabetes: a retrospective cohort study [Abstract]. Value in Health 13 (3) , A56. 10.1016/S1098-3015(10)72257-9

Currie, Craig John and Poole, Christopher David 2010. Survival as a function of HbA1c in people with type 2 diabetes – Authors' reply. The Lancet 375 (9724) , pp. 1434-1435. 10.1016/S0140-6736(10)60616-2

Currie, Craig John, Gale, E. A. and Poole, Christopher David 2010. PCN16 Cancer incidence is influenced by insulin dose and metformin in type 2 diabetes [Abstract]. Value in Health 13 (3) , A26. 10.1016/S1098-3015(10)72107-0

Morgan, Christopher L., Poole, Christopher David, Jenkins-Jones, Sara, Evans, Louise Marie and Currie, Craig John 2010. PDB15 Weight change for patients with type 2 diabetes: secular trends and impact of different combinations of therapy [Abstract]. Value in Health 13 (7) , A286. 10.1016/S1098-3015(11)72073-3

Poole, Christopher David, Connolly, Mark P., Nielsen, Sandy Kildegaard, Currie, Craig John and Marteau, Philippe 2010. A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis. Journal of Crohn's and Colitis 4 (3) , pp. 275-282. 10.1016/j.crohns.2009.11.010

Currie, Craig John, Peters, John Redmond, Tynan, Aodán, Evans, Marc, Heine, Robert J., Bracco, Oswaldo L., Zagar, Tony and Poole, Christopher David 2010. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. The Lancet 375 (9713) , pp. 481-489. 10.1016/S0140-6736(09)61969-3

Poole, Christopher David, Lebmeier, M., Ara, R., Rafia, R. and Currie, Craig John 2010. Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK. Rheumatology 49 (10) , pp. 1949-1956. 10.1093/rheumatology/keq182

Currie, Craig John, Gale, E. A. M. and Poole, Christopher David 2010. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007. Diabetic Medicine 27 (8) , pp. 938-948. 10.1111/j.1464-5491.2010.03040.x

Poole, Christopher David, Chambers, C., Allsopp, R. and Currie, Craig John 2010. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids. Journal of the European Academy of Dermatology and Venereology 24 (6) , pp. 674-678. 10.1111/j.1468-3083.2009.03485.x

Currie, Craig John, Poole, Christopher David and Gale, E. A. M. 2009. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52 (9) , pp. 1766-1777. 10.1007/s00125-009-1440-6

Ellis, Paul, Barrett-Lee, Peter, Johnson, Lindsay, Cameron, David, Wardley, Andrew, O'Reilly, Susan, Verrill, Mark, Smith, Ian, Yarnold, John, Coleman, Robert, Earl, Helena, Canney, Peter, Twelves, Chris, Poole, Christopher David, Bloomfield, David, Hopwood, Penelope, Johnston, Stephen, Dowsett, Mitchell, Bartlett, John M. S., Ellis, Ian, Peckitt, Clare, Hall, Emma and Bliss, Judith M. 2009. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. The Lancet 373 (9676) , pp. 1681-1692. 10.1016/S0140-6736(09)60740-6

Currie, Craig John, Poole, Christopher David and Papo, P. L. 2009. PDB64 A review of retrospective, continuous glucose monitoring: an example of a medical device where the typical primary outcome measure may be inappropriate? [Abstract]. Value in Health 12 (3) , A109. 10.1111/j.1524-4733.2009.00537_2.x

Poole, Christopher David, Chambers, C., Allsopp, Richard and Currie, Craig John 2009. PSS15 Changes in health related utility among adults with atopic dermatitis treated with tacrolimus ointment compared to a standard corticosteroid regimen [Abstract]. Value in Health 12 (3) , A77. 10.1111/j.1524-4733.2009.00537_2.x

Connolly, Mark P., Nielsen, Sandy K., Currie, Craig John, Poole, Christopher David and Travis, Simon P. L. 2009. An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial. Journal of Crohn's and Colitis 3 (1) , pp. 32-37. 10.1016/j.crohns.2008.10.004

Currie, Craig John, Poole, Christopher David and Papo, Natalie L. 2009. An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes. Current Medical Research and Opinion 25 (10) , pp. 2389-2400. 10.1185/03007990903094452

Poole, Christopher David, Sidhu, M. and Currie, Craig John 2008. PSS39 Estimating health related utility from symptom severity in atopic dermatitis (eczema) [Abstract]. Value in Health 11 (3) , A296. 10.1016/S1098-3015(10)70934-7

Currie, Craig John, Sidhu, M. and Poole, Christopher David 2008. PSS37 Mapping the dermatology quality of life index (DLQI) to health-related utility via the SF-12 in subjects with eczema [Abstract]. Value in Health 11 (3) , A295-A296. 10.1016/S1098-3015(10)70932-3

Poole, Christopher David, Nielsen, S. K., Currie, Craig John and Connolly, M. 2008. PGI25 Establishing the relationship between the ulcerative colitis disease activity instrument(UCDAI) and patient health related quality of life from a large randomised controlled trial [Abstract]. Value in Health 11 (6) , A526. 10.1111/j.1524-4733.2008.00453_2.x

Connolly, M., Nielsen, S. K., Currie, Craig John and Poole, Christopher David 2008. PGI10 Once daily mesalazine for maintaining remission is cost-saving compared to twice daily mesalazine: an economic evaluation based on the podium randomised controlled trial [Abstract]. Value in Health 11 (6) , A521. 10.1111/j.1524-4733.2008.00453_2.x

Poole, Christopher David, Nielsen, S. K., Currie, Craig John and Connolly, M. 2008. PGI23 Quality of life (health-related utility) in adults with ulcerative colitis in remission vs. mild/moderate and severe relapse: findings from the podium study [Abstract]. Value in Health 11 (6) , A525. 10.1111/j.1524-4733.2008.00453_2.x

Poole, Christopher David, Conway, P. and Currie, Craig John 2008. An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology 48 (1) , pp. 78-82. 10.1093/rheumatology/ken415

Alcolado, J., Poole, Christopher David, Peters, John Redmond and Currie, Craig John 2008. Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues. Diabetic Medicine 25 (1) , pp. 115-116. 10.1111/j.1464-5491.2007.02335.x

Currie, Craig John, Poole, Christopher David, Tynan, A. and Simpson, A. 2007. An evaluation of treatment discontinuation patterns in people with type 1 and type 2 diabetes switched to alternative short acting insulin. Value in Health 10 (6) , A270. 10.1016/s1098-3015(10)65001-2

Currie, Craig John, Poole, Christopher David, Woehl, Anette, Morgan, Christopher L., Cawley, S., Rousculp, M. D., Covington, M. T. and Peters, John Redmond 2007. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabetic Medicine 24 (2) , pp. 187-194. 10.1111/j.1464-5491.2006.02057.x

Bliss, Judith M., Johnson, Lindsay, Lawrence, D., Peto, J., Price, D., Yarnold, J., Barrett-Lee, Peter, Brunt, A. M., Dodwell, D., Earl, H., Fernando, I., Foster, L., George, W. D., Harnett, A. M., Perin, T., Poole, Christopher David, Raina, V. and Robinson, A. 2007. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. Journal of the National Cancer Institute 99 (7) , pp. 516-525. 10.1093/jnci/djk109

Currie, Craig John, Evans, M. and Poole, Christopher David 2007. Letter [Letter]. Diabetes, Obesity and Metabolism 10 (1) , pp. 94-95. 10.1111/j.1463-1326.2007.00829.x

Currie, Craig John, Poole, Christopher David and Conway, P. 2007. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 94 (4) , pp. 457-462. 10.1136/hrt.2007.118794

Currie, Craig John, Tetlow, A. P., Holmes, P., Poole, Christopher David and McEwan, Philip Christopher 2006. An evaluation of diabetes control and reports of hypoglycaemia in UK general practice following initiation of insulin glargine versus insulin detemir using observational, real-life data [Abstract]. Value in Health 9 (6) , A224. 10.1016/S1098-3015(10)63272-X

Poole, Christopher David, Tetlow, A. P., Holmes, P., McEwan, Philip Christopher and Currie, Craig John 2006. An evaluation of the cost of diabetes-related medication following initiation of treatment with insulin glargine versus insulin detemir in the UK from observational, real-life data from general practice [Abstract]. Value in Health 9 (6) , A224-A225. 10.1016/S1098-3015(10)63274-3

McEwan, Philip Christopher, Poole, Christopher David, Holmes, P., Tetlow, A. P. and Currie, Craig John 2006. The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes [Abstract]. Value in Health 9 (6) , A225-A226. 10.1016/S1098-3015(10)63277-9

McEwan, Philip Christopher, Tetlow, A. P., Holmes, P., Poole, Christopher David and Currie, Craig John 2006. The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 2 diabetes [Abstract]. Value in Health 9 (6) , A227-A228. 10.1016/S1098-3015(10)63283-4

Currie, Craig John, Poole, Christopher David, Woehl, Anette, Morgan, Christopher L., Cawley, S., Rousculp, M. D., Covington, M. T. and Peters, John Redmond 2006. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 49 (10) , pp. 2272-2280. 10.1007/s00125-006-0380-7

Currie, Craig John, McEwan, Philip Christopher, Poole, Christopher David, Odeyemi, Isaac A. O., Datta, Shibendra N. and Morgan, Christopher L. 2006. The impact of the overactive bladder on health-related utility and quality of life. BJU International 97 (6) , pp. 1267-1272. 10.1111/j.1464-410X.2006.06141.x

Poole, Christopher David, Odeyemi, I. A., McEwan, Philip Christopher and Currie, Craig John 2005. The impact of the overactive bladder on quality of life (SF36) and utility (EQ5D) [Abstract]. Value in Health 8 (6) , A85. 10.1016/S1098-3015(10)67402-5

This list was generated on Sun May 5 14:35:43 2024 BST.


Maintained by Cardiff University Information Services